Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.93 -0.25 (-2.44%)
As of: Oct 2, 2026 · 12:25 PM EDT

Zevra Therapeutics (ZVRA) EV to FCF (2021 - 2026)

Updated

Zevra Therapeutics' (ZVRA) EV to FCF came in at 19.29 for Q2 2026, down 33.9% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) EV to FCF (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to FCF at Zevra Therapeutics was 1.17; for FY2021, it came in at 48.12.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Zevra Therapeutics 650.98 Mn -161.73 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.29
Mar 31, 2026 29.21
Mar 31, 2022 26.16
Dec 31, 2021 48.12
Sep 30, 2021 52.14
Jun 30, 2021 64.79
API Access

Zevra Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=ZVRA&period=max&api_key=YOUR_API_KEY